Obligation of User Fee Collections in FY 2010
The user fees collected are expended only for costs necessary to support the process for the review of medical device applications, as defined in MDUFMA. The allowable and excludable costs for the process for the review of medical device applications are defined in Appendix D. As shown in the table 2, FDA obligated $57,187,100 from medical device user fees in FY 2010. Table 2 provides a breakout of user fee obligations by expense category.
FY 2010 Medical Device User Fee Obligations by Expense Category
As of September 30, 2010
Personnel Compensation and Benefits
Travel and Transportation
Equipment and Supplies
1Other includes expense categories like printing & reproduction, and other miscellaneous expenses.
(More information about the costs of the process for device review, as defined in MDUFMA, begins on page 7.)